- Cuomo supports Binghamton University's pharmacy school
- New York's online database of drug prescriptions curtailing 'doctor shopping'
- Reports: Tops Friendly Markets management buys chain from Morgan Stanley Capital Partners
- SheaMoisture to sponsor Korto Momolu collection at NY Fashion Week
- Bitcoin gains popularity among retailers
NEW YORK — The National Advertising Division of the Council of Better Business Bureaus on Monday recommended that Barlow Herbal Specialties discontinue advertising its LDM-100 dietary supplement as a "plant or herb antibiotic."
In its advertising statement, Barlow agreed to discontinue the challenged claims. However, a video embedded on the company's website as of Feb. 14 touted LDM-100 as an "antiviral" and "antifungal" good for use during cold and flu season.
Dietary supplements may not be advertised to diagnose, treat, cure or prevent any disease as clarified in the Dietary Supplement Health and Education Act of 1994.
NAD had requested substantiation of Barlow Herbal's claims as part of the division's routine monitoring program through a grant from the CRN Foundation.